LABOFLEX Acne Spot Care by Laboflex, Inc. / WOOSHIN LAPACHE d.o.o. LABOFLEX Acne Spot Care

LABOFLEX Acne Spot Care by

Drug Labeling and Warnings

LABOFLEX Acne Spot Care by is a Otc medication manufactured, distributed, or labeled by Laboflex, Inc., WOOSHIN LAPACHE d.o.o.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

LABOFLEX ACNE SPOT CARE- salicylic acid 0.5% patch 
Laboflex, Inc.

----------

LABOFLEX Acne Spot Care

Drug Facts

Active Ingredients

Salicylic Acid 0.5%

Purpose

Acne Treatment

Uses

  • For the treatment of acne

Directions

  • Cleanse thoroughly before applying this product
  • Cover the entire affected area with patch
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor
  • If bothersome dryness or peeling occurs, reduce application to once a day or even every other day

Inactive Ingredients

Carboxymethylcellulose Sodium, Dihydroxyaluminum Aminoacetate, Edetate Sodium, Glycerin, Methyl- paraben, Mint Oil, Partially Neutralized Polyacrylic Acid, Polysorbate 80, Povidone-K90, Propylparaben, Propylene Glycol, Sodium Polyacrylate, Tartaric Acid, Titanium Dioxide, Purified Water

Questions of comments?

Call toll-free 1-800-655-0252 or email: wooshinlabo-us@wooshinmed.com

Warnings

For external use only.

Keep out of reach of children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control center right away

Product Packaging

Carton

CartonLabel

LABOFLEX ACNE SPOT CARE 
salicylic acid 0.5% patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 83655-105
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)  
DIHYDROXYALUMINUM AMINOACETATE (UNII: DO250MG0W6)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
MINT (UNII: FV98Z8GITP)  
POLYACRYLIC ACID (8000 MW) (UNII: 73861X4K5F)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
WATER (UNII: 059QF0KO0R)  
TARTARIC ACID (UNII: W4888I119H)  
POVIDONE K90 (UNII: RDH86HJV5Z)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
EDETATE SODIUM (UNII: MP1J8420LU)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 83655-105-2140 in 1 CARTON09/27/202309/27/2023
10.25 g in 1 PATCH; Type 0: Not a Combination Product
2NDC: 83655-105-1130 in 1 POUCH09/27/202309/27/2023
20.25 g in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00609/27/202309/27/2023
Labeler - Laboflex, Inc. (128394050)
Registrant - Laboflex, Inc. (128394050)
Establishment
NameAddressID/FEIBusiness Operations
WOOSHIN LAPACHE d.o.o.507385209manufacture(83655-105)

Revised: 12/2024
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.